Company / Operating Income per Share
Vistagen Therapeutics, Inc. Operating Income per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.49
FY2021
5-year range
-$11.45 / -$0.49
FY2017-FY2021
Trend
+75.7%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-11.45 to $-0.49 over the past 4 years.
Based on SEC 10-K filings.
-0.49 in FY2021.
Improved from $-11.45 to $-0.49 over the past 4 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, operating income per share increased 75.7% year-over-year.
- Peak operating income per share was recorded in FY2014.
- Lowest operating income per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$0.49 | +75.7% |
| FY2018 | -$2.01 | +82.4% |
| FY2017 | -$11.45 | -2951.2% |
| FY2014 | -$0.38 | +53.9% |
| FY2012 | -$0.81 | +35.0% |
| FY2011 | -$1.25 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026